San Diego, CA (PRWEB) May 02, 2013
Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that Robert Sullivan, PhD, dean of the Rady School of Management at the University of California, San Diego (UC San Diego) has agreed to join the Company’s Business Advisory Board. Dr. Sullivan is an expert on entrepreneurship, knowledge management and operations management.
As an Advisor, Dean Sullivan’s specific focus will be Stemedica’s newly formed Cardiology Division which aims to advance Stemedica’s national and international clinical trials in chronic heart failure, acute myocardial infarct and other cardiac conditions. Within this Division, Dr. Sullivan will assist the Company as a liaison between not only the San Diego biotech and business communities, but with organizations worldwide.
As the founding dean of the Rady School of Management, Dr. Sullivan has increased the school’s brand in San Diego and throughout the world. He has successfully recruited top-tier faculty from universities such as the University of Chicago, Massachusetts Institute of Technology (MIT), New York University, Northwestern, Princeton, Stanford, the Wharton School and Yale. In 2011, Dr. Sullivan was elected vice chair-chair elect of the Association to Advance Collegiate Schools of Business (AACSB International), the premier accrediting body for business education.
Dr. Sullivan has held a variety of posts prior to joining the Rady School of Management at UC San Diego. Before coming to San Diego, he was dean of the Kenan-Flagler Business School of The University of North Carolina, Chapel Hill. From 1995 to 1997, he served as director of the University of Texas at Austin’s IC2 Institute, a nontraditional international center for research and education on innovation, creativity, capital and commercialization. Dr. Sullivan served as dean of the Graduate School of
Copyright©2012 Vocus, Inc.
All rights reserved